2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Description: Percentage of patients aged 18 years and older with a diagnosis ofContinue reading “2025 #6 MIPS Measure Coronary Artery Disease (CAD): Antiplatelet Therapy”
CQMS Archive
2025 #5 MIPS Measure Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Description: Percentage of Patients Aged 18 Years and Older with A Diagnosis ofContinue reading “2025 #5 MIPS Measure Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)”
2025 #1 MIPS Measure Diabetes: Glycemic Status Assessment Greater Than 9%
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE:Intermediate Outcome – High Priority Description: Percentage of patients 18-75 years of age with diabetesContinue reading “2025 #1 MIPS Measure Diabetes: Glycemic Status Assessment Greater Than 9%”